journal article·2023-02Open access

pH-responsive nanoparticles based on POEOMA-b-PDPA block copolymers for RNA encapsulation, protection and cell delivery

Bruno Baptista, Andreia S.R. Oliveira, Patrícia Mendonça, Arménio C. Serra, Jorge F.J. Coelho, Fani Sousa

Abstract

The use of gene-based products, such as DNA or RNA, is increasingly being explored for various innovative therapies. However, the success of these strategies is highly dependent on the effective delivery of these biomolecules to target cells. Therefore, the development of pH-responsive nanoparticles comprises the creation of intelligent delivery systems with high therapeutic efficiency. In this work, the pH-responsiveness of the poly(2-(diisopropylamino)ethyl methacrylate)) (PDPA) block was investigated for the encapsulation and delivery of small RNAs (sRNA) to cancer cells. The pH responsiveness was dependent on the protonation profile of the tertiary amines of PDPA, which directly affected the electrostatic interactions established with RNA. Thus, block copolymers based on poly(oligo(ethylene oxide) methyl ether methacrylate) (POEOMA) and PDPA, POEOMA- b -PDPA, were synthesized by supplemental activator and reducing agent atom transfer radical polymerization (SARA ATRP). The structure of the block copolymers was characterized by size exclusion chromatography and 1 H NMR spectroscopy. The copolymers allowed effective complexation of model sRNAs and a pre-miRNA with efficiencies of about 89 % and 91 %, respectively. The characterization by dynamic light scattering revealed that these systems had sizes between 76 and 1375 nm. It was also found that the morphology of the polyplexes depended on the pH, since the preparation at a pH lower than the p K a of the copolymers resulted in spherical but polydisperse particles, while higher pH values resulted in nanoparticles with more homogeneous size, but altered morphology. Moreover, due to pH-responsiveness, it was achieved the release of RNA at pH higher than the p K a of the copolymers, while maintaining its integrity. The polyplexes also showed a high potential to protect RNA from RNases. The transfection of a lung cancer model (A549) and fibroblast cell lines showed that these polyplexes did not cause cell toxicity. In addition, the polyplexes enabled the effective transfection of the A549 cell line with pre-miRNA-29b and miRNA-29b, resulting in a decrease of expression levels of the target DNMT3B gene by approximately 51 % and 47 %, respectively. Overall, the POEOMA- b -PDPA copolymers proved to be a promising strategy for developing responsive delivery systems, that can play a critical role in some diseases, such as cancer, where pH varies between the intra and extracellular environments.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Fuel Cells and Related Materials · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (75)

Show source-provided references
1. Dilemma on plasmid DNA purification: binding capacity vs selectivity10.1016/j.chroma.2020.461848 ↗
2. Characterization of polyplexes involving small RNA10.1016/j.jcis.2012.07.088 ↗
3. mRNA, a revolution in biomedicine10.3390/pharmaceutics13122090 ↗
5. Regulation of microRNA function in animals10.1038/s41580-018-0045-7 ↗
6. RNA therapeutics - research and clinical advancements
7. Noncoding RNAs regulate alternative splicing in cancer10.1186/s13046-020-01798-2 ↗
8. Role of RNA modifications in cancer10.1038/s41568-020-0253-2 ↗
9. Non-coding RNAs: emerging from the discovery to therapeutic applications10.1016/j.bcp.2021.114469 ↗
10. 2 - nanoparticles as nucleic acid delivery vectors
11. Chapter 35 - gene delivery into cells and tissues
12. Synthesis and characterization of new temperature-responsive nanocarriers based on POEOMA-b-PNVCL prepared using a combination of ATRP, RAFT and CuAAC10.1016/j.eurpolymj.2016.06.011 ↗
13. Üzgün · Biomacromolecules · 2010 · 11 · 3910.1021/bm9008759 ↗
14. Synthesis and physicochemical characterization of amphiphilic triblock copolymer brush containing pH-sensitive linkage for oral drug delivery10.1021/la301099q ↗
15. Antifouling and pH-responsive poly(carboxybetaine)-based nanoparticles for tumor cell targeting
16. Tumour acidosis: from the passenger to the driver’s seat10.1038/nrc.2017.77 ↗
17. Dysregulated pH: a perfect storm for cancer progression10.1038/nrc3110 ↗
18. Efficient encapsulation of plasmid DNA in pH-sensitive PMPC–PDPA polymersomes: study of the effect of PDPA block length on copolymer–DNA binding affinity10.1002/mabi.201000083 ↗
19. pH-triggered block copolymer micelles based on a pH-responsive PDPA (poly[2-(diisopropylamino)ethyl methacrylate]) inner core and a PEO (poly(ethylene oxide)) outer shell as a potential tool for the cancer therapy10.1039/c1sm05992k ↗
20. Preparation of well-defined brush-like block copolymers for gene delivery applications under biorelevant reaction conditions10.1016/j.colsurfb.2018.05.004 ↗
21. Reversible reaction of dioxygen (and carbon monoxide) with a copper(I) complex. X-ray structures of relevant mononuclear Cu(I) precursor adducts and the trans-(.mu.-1,2-peroxo)dicopper(II) product10.1021/ja00060a017 ↗
22. Effect of chain length on cytotoxicity and endocytosis of cationic polymers10.1021/ma102498g ↗
23. New insights for therapeutic recombinant human miRNAs heterologous production: Rhodovolum sulfidophilum vs Escherichia coli10.1080/21655979.2017.1284710 ↗
24. A new affinity approach to isolate Escherichia coli 6S RNA with histidine-chromatography10.1002/jmr.1078 ↗
25. Chitosan-based formulations for delivery of DNA and siRNA10.1016/j.addr.2009.08.004 ↗
26. Engineering of pH-triggered nanoplatforms based on novel poly(2-methyl-2-oxazoline)-b-poly[2-(diisopropylamino)ethyl methacrylate] diblock copolymers with tunable morphologies for biomedical applications10.1039/D1PY00141H ↗
27. Effect of pH and temperature on PMPC–PDPA copolymer self-assembly10.1021/ma302228m ↗
28. Triple-layered pH-responsive micelleplexes loaded with siRNA and cisplatin prodrug for NF-kappa B targeted treatment of metastatic breast cancer10.7150/thno.13515 ↗
29. pH-sensitive block copolymer vesicles with variable trigger points for drug delivery10.1021/ma3015728 ↗
30. Nanoparticles of the poly([N-(2-hydroxypropyl)]methacrylamide)-b-poly[2-(diisopropylamino)ethyl methacrylate] diblock copolymer for pH-triggered release of paclitaxel10.1039/C5PY00567A ↗
31. Non-cytotoxic polymer vesicles for rapid and efficient intracellular delivery10.1039/b717431d ↗
32. Biomimetic pH sensitive polymersomes for efficient DNA encapsulation and delivery10.1002/adma.200700941 ↗
33. Encapsulation of biomacromolecules within polymersomes by electroporation10.1002/anie.201204169 ↗
34. Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery10.1021/mp900090z ↗
35. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles
36. Self-assembled PEG-b-PDPA-b-PGEM copolymer nanoparticles as protein antigen delivery vehicles to dendritic cells: preparation, characterization and cellular uptake10.1093/rb/rbw044 ↗
37. Messenger RNA (mRNA) nanoparticle tumour vaccination10.1039/C4NR01346H ↗
38. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells10.1021/nl052396o ↗
39. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function10.1016/j.biomaterials.2009.09.060 ↗
40. Application of circular dichroism to study RNA folding transitions10.1016/S0076-6879(00)17026-0 ↗
41. Techniques to analyze sRNA protein cofactor self-assembly in vitro10.1007/978-1-4939-7634-8_18 ↗
42. Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures10.1208/ps040312 ↗
43. Decoding cold ischaemia time impact on kidney graft: the kinetics of the unfolded protein response pathways10.1080/21691401.2018.1518908 ↗
44. The role of miR-29b in cancer: regulation, function, and signaling
45. Diverse roles of miR-29 in cancer (review)10.3892/or.2014.3036 ↗
46. Before and after endosomal escape: roles of stimuli-converting siRNA/polymer interactions in determining gene silencing efficiency10.1021/ar200241v ↗
47. Overview of microRNA biogenesis, mechanisms of actions, and circulation10.3389/fendo.2018.00402 ↗
48. MicroRNAs with a nucleolar location10.1261/rna.1470409 ↗
49. Pre-microRNA and mature microRNA in human mitochondria
50. Changes in nuclear and cytoplasmic microRNA distribution in response to hypoxic stress10.1038/s41598-019-46841-1 ↗
51. A stress-induced response complex (SIRC) shuttles miRNAs, siRNAs, and oligonucleotides to the nucleus10.1073/pnas.1721346115 ↗
52. The microRNA biology of the mammalian nucleus10.1038/mtna.2014.40 ↗
53. RNAi factors are present and active in human cell nuclei10.1016/j.celrep.2013.12.013 ↗
54. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs10.1016/j.molcel.2004.07.007 ↗
55. A comprehensive characterization of the nuclear microRNA repertoire of post-mitotic neurons10.3389/fnmol.2013.00043 ↗
56. A hexanucleotide element directs microRNA nuclear import10.1126/science.1136235 ↗
57. Dynamic localisation of mature microRNAs in human nucleoli is influenced by exogenous genetic materials
58. Deep sequencing of human nuclear and cytoplasmic small RNAs reveals an unexpectedly complex subcellular distribution of miRNAs and tRNA 3′ trailers
59. Mature microRNAs identified in highly purified nuclei from HCT116 colon cancer cells10.4161/rna.7.5.13215 ↗
60. Nuclear microRNAs and their unconventional role in regulating non-coding RNAs10.1007/s13238-013-3001-5 ↗
61. CRM1 mediates nuclear-cytoplasmic shuttling of mature microRNAs10.1073/pnas.0912384106 ↗
62. Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs10.1016/j.cell.2008.12.023 ↗
63. Importin 8 regulates the transport of mature microRNAs into the cell nucleus10.1074/jbc.C113.541417 ↗
64. Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer10.1186/s12943-018-0765-5 ↗
65. DNA methyltransferases in cancer: biology, paradox, aberrations, and targeted therapy10.3390/cancers12082123 ↗
66. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B10.1073/pnas.0707628104 ↗
67. A double-negative feedback interaction between microRNA-29b and DNMT3A/3B contributes to ovarian cancer progression10.1159/000447926 ↗
68. miR-29 represses the activities of DNA methyltransferases and DNA demethylases10.3390/ijms140714647 ↗
69. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma10.1038/s41419-018-1281-7 ↗
70. A systematic review of miR-29 in cancer10.1016/j.omto.2018.12.011 ↗
71. Therapeutic delivery of microRNA-29b by cationic lipoplexes for lung cancer10.1038/mtna.2013.14 ↗
72. Downregulation of miR-29b targets DNMT3b to suppress cellular apoptosis and enhance proliferation in pancreatic cancer10.3892/mmr.2017.6827 ↗
73. miR-29b upregulates miR-195 by targeting DNMT3B in tongue squamous cell carcinoma10.1007/s11434-016-1001-6 ↗
74. Recombinant pre-miR-29b for Alzheimer’s disease therapeutics10.1038/srep19946 ↗
75. Cationic polymer optimization for efficient gene delivery10.2174/138955710791185109 ↗